September 06, 2017
                                    
                                    The largest supplier of generic drugs globally, India continues to fortify its reputation as a hub for the production of affordable quality medicines.
                                 
                             
                        
                            
                                
                                
                                    
                                    
                                    June 19, 2017
                                    
                                    Firms must shift focus from Quality for Compliance to Quality as a Culture by keeping the end patient in mind.
                                 
                             
                        
                            
                                
                                
                                    
                                    
                                    June 19, 2017
                                    
                                    Maintaining Safeguards Whilst Lowering Barriers to Market Entry.
                                 
                             
                        
                            
                                
                                
                                    
                                    
                                    May 24, 2017
                                    
                                    The cost of developing new drugs and cures is enormous. A delicate balance between encouraging innovation and controlling the cost of medicines has to be maintained.
                                 
                             
                        
                            
                                
                                
                                    
                                    
                                    May 09, 2017
                                    
                                    Consolidation and the requirements of new and personalized drugs are changing the playing field.
                                 
                             
                        
                            
                                
                                
                                    
                                    
                                    March 17, 2017
                                    
                                    Slashing drug prices might benefit patients in the short term, but at what cost?
                                 
                             
                        
                            
                                
                                
                                    
                                    
                                    March 01, 2017
                                    
                                    In a time of uncertainty across the board, the United States is still "going boldly” ahead, bringing us innovation and constantly adapting its business model.